West Pharmaceutical Services Inc
WST· NYSE
Released Feb 15, 2018, during market hours
10-K filed Feb 26, 2018, 57 days after period end · 0000105770-18-000006
derived · Computed from the longer spans the company filed.
| Metric | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures |
|---|---|---|---|---|
| Revenue | $415.60M | $382.30M | $359.70M | $349.80M |
| Net Income | $0.00 |
West Pharmaceutical Services Inc · CIK 105770 · Engraved from SEC EDGAR
| $39.20M |
| $33.40M |
| $31.40M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.